Cargando…
What Are the Incentives for Medicare Prescription Drug Plans to Consider Long-Term Outcomes and Cost?
BACKGROUND: Medicare Prescription Drug Plans (PDPs) do not have incentives to consider long-term outcomes and costs associated with both medical and pharmacy benefits (LTOCMP) when making formulary decisions. OBJECTIVE: To identify existing quality measures, payment models, and public reporting tool...
Autores principales: | Hung, Anna, Perfetto, Eleanor M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Academy of Managed Care Pharmacy
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10398251/ https://www.ncbi.nlm.nih.gov/pubmed/27348277 http://dx.doi.org/10.18553/jmcp.2016.22.7.773 |
Ejemplares similares
-
Effects of Physician Report Cards, Knowledge of Drug Prices, and Financial Incentives in Prescription Drug Costs
por: Curtiss, Frederic R.
Publicado: (2003) -
Prescription Drug Expenditures, Financial Burden, and Health Plan Satisfaction Among Medicare Beneficiaries
por: Curtiss, Frederic R.
Publicado: (2003) -
Variation in Estimated Medicare Prescription Drug Plan Costs and Affordability for Beneficiaries Living in Different States
por: Davis, Matthew M., et al.
Publicado: (2007) -
Prescription Drug Benefits: Cost Management Issues for Medicare
por: Fox, Peter D.
Publicado: (2003) -
Comparison of oral anticoagulation use and adherence among Medicare beneficiaries enrolled in stand-alone prescription drug plans vs Medicare Advantage prescription drug plans
por: Newman, Terri Victoria, et al.
Publicado: (2022)